We serve Chemical Name:Cellulose microcrystalline CAS:9004-34-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Cellulose microcrystalline
CAS.NO:9004-34-6
Synonyms:MFCD00081512;Cellulose microcrystalline;Microcrystalline cellulose;1H-Indene, 2,3-dihydro-2,4,7-trimethyl-;2,4,7-Trimethylindane;(1->4)-beta-D-glucan;EINECS 232-674-9;α-Cellulose
Molecular Formula:C6H10O5
Molecular Weight:160.255
HS Code:3912900000
Physical and Chemical Properties:
Melting point:260-270ºC
Boiling point:237.6±35.0 °C at 760 mmHg
Density:0.9±0.1 g/cm3
Index of Refraction:1.529
PSA:
Exact Mass:160.125198
LogP:4.75
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like MFCD00081512 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,α-Cellulose physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,α-Cellulose Use and application,Cellulose microcrystalline technical grade,usp/ep/jp grade.
Related News: Slower growth in pesticide intermediates weighed on industrial business. In the first three quarters, the company’s operating income was 2.977 billion yuan, a year-on-year increase of 2.57%. Cellulose microcrystalline manufacturer The measure starts on February 4, according to South Korean Prime Minister Chung Sye-kyun. Cellulose microcrystalline supplier The FDA also said that the labeling of the diagnostic, which comes in different versions, included performance claims that did not match up with results seen in clinical studies—and that the data Innova submitted for review “was identical to data previously provided by other manufacturers” in separate requests for emergency COVID authorizations, raising additional questions. Cellulose microcrystalline vendor As part of the agreement, ICIG will enter into a 5-year supply contract to provide Genzyme with materials needed for the production of eliglustat tartrate, an investigational treatment for Gaucher disease Type 1 that is currently in Phase III clinical trials. Cellulose microcrystalline factory The measure starts on February 4, according to South Korean Prime Minister Chung Sye-kyun.
